Fig. 3

Prognostic significance of IFI6 in BC patients. (A,B) The OS (A) and RFS (B) in BC cohorts obtained through BC-GEM. (C) ROC curve. (D,E) The OS (D) and RFS (E) in BC cohorts obtained from the Kaplan-Meier plotter database. (F–I) OS curves based on different molecular subtypes: ER-positive (F), PR-positive (G), HER-2 positive (H) and lymph node-positive subtypes (I). (J–M) RFS curves based on different molecular subtypes: ER-positive (J), PR-positive (K), HER-2 positive (L) and lymph node-positive subtypes (M).